LONDON, September 21, 2015 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces that Heliyon, its new open access journal publishing research across all disciplines, has today published its first eight papers since the journal opened for submissions earlier this year.
Covering topics as diverse as Yard-long beans in Sri Lanka and cattle in Western Germany, the newly published papers span multiple research disciplines from authors across four continents. According to Claudia Lupp, Heliyon's Editor in Chief, these first papers demonstrate the journal's commitment to publishing sound research across a broad range of disciplines.
Claudia Lupp said, "I'm delighted that, with the support of our editorial board of over 600 active researchers, we have been able to meet this milestone. The quality of our published content is a reflection of the rigorous criteria we have set and applied throughout the review process."
Heliyon aims to offer authors a superior user experience, drawing on Elsevier's extensive network of cutting-edge technologies to streamline every stage of the publication process. In line with this commitment, the journal is set to be the first in the world to use the newest version of Proof Central, a tool which allows authors to quickly input corrections and immediately generate a final version of their paper's PDF for review - thus speeding up the proofing stage. Using technologies developed at Elsevier and Mendeley, the journal will continue to focus on improving the author, editor, reviewer, and reader experience.
"Heliyon represents an exciting step in scientific publishing. It is a platform for innovation and experimentation that builds on the learnings from journals like Cell and its sister journals to continually explore and evolve how we publish, discover, view and share research," said Emilie Marcus, CEO of Cell Press and Editor-in-Chief of Cell.
The Heliyon team aims to garner maximum visibility for papers, enabling them to be easily discoverable and connected to relevant communities and readers. All published papers are immediately and permanently available to read, download and share on both Heliyon.com and ScienceDirect.
Visit the website http://www.heliyon.com for more information, submission guidelines, and to register for email alerts.
Read more about this news on Elsevier Connect.
Heliyon is an open access journal from Elsevier that publishes robust research across all disciplines. The journal's team of experts ensures that each paper meeting their rigorous criteria is published quickly and distributed widely. Led by Dr. Claudia Lupp, the editorial team consists of over 600 active researchers who review papers on their merit, validity, and technical and ethical soundness. All published papers are immediately and permanently available on both Heliyon.com and ScienceDirect.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey- and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries.
Mary Beth O'Leary
Marketing & Publicity Manager